BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29763858)

  • 1. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
    Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
    Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of menopausal hormone therapy in breast cancer survivors older than fifty at diagnosis: A systematic review and meta-analysis.
    Mudhune GH; Armour M; McBride KA
    Breast; 2019 Oct; 47():43-55. PubMed ID: 31344603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
    Fahlén M; Fornander T; Johansson H; Johansson U; Rutqvist LE; Wilking N; von Schoultz E
    Eur J Cancer; 2013 Jan; 49(1):52-9. PubMed ID: 22892060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis.
    Poggio F; Del Mastro L; Bruzzone M; Ceppi M; Razeti MG; Fregatti P; Ruelle T; Pronzato P; Massarotti C; Franzoi MA; Lambertini M; Tagliamento M
    Breast Cancer Res Treat; 2022 Jan; 191(2):269-275. PubMed ID: 34731351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk.
    Col NF; Hirota LK; Orr RK; Erban JK; Wong JB; Lau J
    J Clin Oncol; 2001 Apr; 19(8):2357-63. PubMed ID: 11304788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence.
    Col NF; Kim JA; Chlebowski RT
    Breast Cancer Res; 2005; 7(4):R535-40. PubMed ID: 15987460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
    O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
    J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis.
    Shim SH; Lee SJ; Kim SN
    Eur J Cancer; 2014 Jun; 50(9):1628-37. PubMed ID: 24685478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer.
    Chlebowski RT; McTiernan A
    J Clin Oncol; 1999 Jan; 17(1):130-42. PubMed ID: 10458226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
    Deli T; Orosz M; Jakab A
    Pathol Oncol Res; 2020 Jan; 26(1):63-78. PubMed ID: 30617760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
    Li D; Ding CY; Qiu LH
    Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies.
    Kim S; Ko Y; Lee HJ; Lim JE
    Breast Cancer Res Treat; 2018 Aug; 170(3):667-675. PubMed ID: 29713854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis.
    Jang YC; Huang HL; Leung CY
    BMC Cancer; 2019 Dec; 19(1):1199. PubMed ID: 31818262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
    Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
    Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
    Rippy L; Marsden J
    Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy in breast cancer patients and survivors.
    Del Priore G; Hatami M
    Curr Womens Health Rep; 2003 Apr; 3(2):165-9. PubMed ID: 12628087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy.
    Durna EM; Heller GZ; Leader LR; Sjoblom P; Eden JA; Wren BG
    Climacteric; 2004 Sep; 7(3):284-91. PubMed ID: 15669553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.